Last quarter (Q ), Cell MedX's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Cell MedX's net income was $-157.24K. See Cell MedX’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	May 23	May 22	May 21	May 20	May 19
Total Revenue	$ 296.00	$ 2.76K	$ 6.07K	$ 7.02K	$ 95.82K	$ 0.00
Cost of Revenue	$ 31.74K	$ -483.00	$ -4.03K	$ -6.76K	$ 10.24K	$ 0.00
Gross Profit	$ -27.00K	$ 3.25K	$ 10.10K	$ 13.79K	$ 85.59K	$ 0.00
Operating Expense	$ 1.27M	$ 448.14K	$ 1.35M	$ -1.41M	$ 1.12M	$ 670.21K
Operating Income	$ -1.64M	$ -893.04K	$ -1.34M	$ 1.43M	$ -1.04M	$ -670.21K
Net Non Operating Interest Income Expense	$ -70.82K	$ -47.38K	$ -25.69K	$ -32.02K	$ -21.07K	$ -235.77K
Other Income Expense	-	-	-	$ 42.57K	$ -33.28K	-
Pretax Income	$ -1.70M	$ -821.83K	$ -1.30M	$ 1.28M	$ -1.09M	$ -905.98K
Tax Provision	$ -104.00K	$ -104.00K	$ -146.45K	$ 153.66K	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.04M	$ -1.32M	$ -2.00M	$ 215.00K	$ -1.09M	$ -905.98K
Basic EPS	$ -0.01	$ -0.01	$ -0.01	$ -0.02	$ -0.02	$ -0.02
Diluted EPS	$ -0.01	$ -0.01	$ -0.01	$ -0.02	$ -0.02	$ -0.02
Basic Average Shares	$ 251.69M	$ 62.92M	$ 62.80M	$ 58.76M	$ 53.48M	$ 44.28M
Diluted Average Shares	$ 251.69M	$ 62.92M	$ 62.80M	$ 58.76M	$ 53.48M	$ 44.28M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.30M	$ 447.66K	$ 1.35M	$ -1.42M	$ 1.13M	$ 670.21K
Net Income From Continuing And Discontinued Operation	$ -1.16M	$ -495.04K	$ -2.00M	$ 215.00K	$ -1.09M	$ -905.98K
Normalized Income	$ -1.76M	$ -925.83K	-	-	$ -1.06M	$ -905.98K
Interest Expense	-	-	-	-	$ 21.07K	$ 16.72K
EBIT	$ -1.63M	$ -774.44K	$ -1.27M	$ 1.31M	$ -1.04M	$ -889.26K
EBITDA	$ -1.63M	$ -774.44K	$ -1.27M	$ 1.31M	$ -1.04M	$ -888.68K

Currency in USD

Cell MedX Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing